耐信联合黛力新治疗老年伴抑郁非糜烂性胃食管反流病的疗效及对生活质量的影响

Efficacy of Deanxit in management of negative emotions in patients with digestive system malignant tumors

AIM: To evaluate the clinical efficacy of Deanxit in the management of negative emotions in patients with digestive system malignant tumors.

METHODS: One hundred and thirty-three patients with digestive system malignant tumors and negative emotions treated at the Nanchang Hospital of Integrated Traditional Chinese Medicine and Western Medicine from October 2012 to October 2014 were divided into either a treatment group (n = 68) or a control group (n = 65). There was no significant difference in tumor histology, distribution, age, gender or course of disease between the two groups. Patients in both groups were given conventional anti-cancer therapy, and Deanxit and placebo were additionally given to the treatment group and control group, respectively. All patients were followed once every two weeks, during which Hamilton Depression Scale (HAMD) score, Hamilton Anxiety Scale (HAMA) score and any side effects were assessed. Treatment outcomes were evaluated after 8 weeks of treatment.

RESULTS: After 8 weeks of treatment, patients from both groups showed significant relief in terms of depression (HAMD, treatment group: 8.5 ± 3.2 vs 23.1 ± 4.5; control group: 12.3 ± 5.2 vs 22.9 ± 4.1) and anxiety (HAMA, treatment group: 7.8 ± 2.6 vs 25.9 ± 4.3; control group: 14.5 ± 4.4 vs 26.1 ± 4.7; P < 0.05 both). Symptom relief was more significant in the treatment group than in control group, as demonstrated by both HAMD (8.5 ± 3.2 vs 12.3 ± 5.2, P < 0.05) and HAMA (7.8 ± 2.6 vs 14.5 ± 4.4, P < 0.05).

CONCLUSION: Deanxit is effective and safe in the management of negative emotions in patients with digestive system malignant tumors and can help improve the quality of life of patients.